Cardinal Health INC DEF 14A proxy statements
Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.
NYSE
Cardinal Health, Inc. has filed a Definitive Proxy Statement with the SEC.
NYSE
Cardinal Health achieved double-digit profit growth across all operating segments in fiscal 2025, driven by strategic acquisitions and operational efficiencies, despite a major contract expiration.
NYSE
DEFA14A: Cardinal Health Files Supplement to Proxy Statement Regarding Clawback Policy and Accounting Error
Cardinal Health filed a supplement to its proxy statement to include Inline XBRL tagging and clarify the application of its clawback policy following the correction of an accounting error related to revenue recognition in the at-Home Solutions segment.
NYSE
DEFA14A: Cardinal Health Updates Proxy Statement Following Director's Appointment as Interim CEO of Masimo
Cardinal Health has updated its proxy statement to reflect that director Michelle M. Brennan no longer qualifies as an independent director due to her appointment as interim CEO of Masimo Corporation, a company with which Cardinal Health has a significant commercial relationship.
NYSE
Cardinal Health has filed a definitive proxy statement with the Securities and Exchange Commission.
NYSE
DEF 14A: Cardinal Health's Proxy Statement Highlights Strong Fiscal 2024 Performance and Strategic Focus
Cardinal Health's proxy statement emphasizes a strong fiscal 2024 performance driven by strategic progress and shareholder value creation.